Nisa Investment Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,224
| Closed | -$293K | – | 3127 |
|
|
2025
Q1 | $293K | Sell |
2,224
-452
| -17% | -$56.3K | ﹤0.01% | 1137 |
|
|
2024
Q4 | $224K | Hold |
2,676
| – | – | ﹤0.01% | 1265 |
|
|
2024
Q3 | $196K | Sell |
2,676
-1,492
| -36% | -$112K | ﹤0.01% | 1283 |
|
|
2024
Q2 | $285K | Sell |
4,168
-137
| -3% | -$9.5K | ﹤0.01% | 1229 |
|
|
2024
Q1 | $298K | Buy |
4,305
+73
| +2% | +$5.02K | ﹤0.01% | 1222 |
|
|
2023
Q4 | $303K | Sell |
4,232
-190
| -4% | -$10.9K | ﹤0.01% | 1190 |
|
|
2023
Q3 | $230K | Sell |
4,422
-15,200
| -77% | -$886K | ﹤0.01% | 1269 |
|
|
2023
Q2 | $1.24M | Buy |
19,622
+15,180
| +342% | +$946K | 0.01% | 824 |
|
|
2023
Q1 | $241K | Sell |
4,442
-20
| -0.4% | -$967 | ﹤0.01% | 1266 |
|
|
2022
Q4 | $236K | Hold |
4,462
| – | – | ﹤0.01% | 1315 |
|
|
2022
Q3 | $205K | Buy |
4,462
+371
| +9% | +$19.4K | ﹤0.01% | 1265 |
|
|
2022
Q2 | $234K | Sell |
4,091
-520
| -11% | -$29.5K | ﹤0.01% | 1265 |
|
|
2022
Q1 | $282K | Sell |
4,611
-4,258
| -48% | -$221K | ﹤0.01% | 1251 |
|
|
2021
Q4 | $421K | Buy |
8,869
+47
| +0.5% | +$1.97K | ﹤0.01% | 1066 |
|
|
2021
Q3 | $329 | Buy |
8,822
+122
| +1% | +$4.24K | ﹤0.01% | 1244 |
|
|
2021
Q2 | $355 | Hold |
8,700
| – | – | ﹤0.01% | 1231 |
|
|
2021
Q1 | $295 | Hold |
8,700
| – | – | ﹤0.01% | 1348 |
|
|
2020
Q4 | $277K | Buy |
8,700
+1,225
| +16% | +$32.2K | ﹤0.01% | 1349 |
|
|
2020
Q3 | $192K | Sell |
7,475
-2,847
| -28% | -$65K | ﹤0.01% | 1319 |
|
|
2020
Q2 | $265K | Buy |
10,322
+472
| +5% | +$9.55K | ﹤0.01% | 1212 |
|
|
2020
Q1 | $151K | Buy |
9,850
+470
| +5% | +$10.2K | ﹤0.01% | 1266 |
|
|
2019
Q4 | $322K | Hold |
9,380
| – | – | ﹤0.01% | 1217 |
|
|
2019
Q3 | $70K | Buy |
+9,380
| New | +$89.9K | ﹤0.01% | 1506 |
|
|
2016
Q4 | – | Sell |
-500
| Closed | -$8K | – | 1897 |
|
|
2016
Q3 | $8K | Hold |
500
| – | – | ﹤0.01% | 1814 |
|
|
2016
Q2 | $19K | Hold |
500
| – | – | ﹤0.01% | 1632 |
|
|
2016
Q1 | $14K | Buy |
+500
| New | +$16.7K | ﹤0.01% | 1715 |
|
Other funds holding ITCI
KIM
HNB
Nisa Investment Advisors's ITCI Position: Q2 2025 in Review
Nisa Investment Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,224 shares — an estimated $293K sold.
Nisa Investment Advisors first reported a position in ITCI in Q1 2016 and held it in 26 quarters. The position peaked at $1.24M in Q2 2023. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- Nisa Investment Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- Nisa Investment Advisors sold 2,224 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $293K.
- Nisa Investment Advisors first reported a position in Intra-Cellular Therapies Inc. in Q1 2016 and held it in 26 quarters.
- Nisa Investment Advisors's Intra-Cellular Therapies Inc. position peaked at $1.24M in Q2 2023.
- 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on Nisa Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.